Birdwatch Archive

Birdwatch Note

2024-10-16 10:51:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Lin Yu-Ting and Imane Khelif never legally disputed genetic tests done in globally accredited labs showing XY karyotype. Khelif’s trainer admitted third test revealed ‘problems with chromosomes and hormones’; Khelif’s lawyers compare case to 46 XY DSD, Caster Semenya. https://www.3wiresports.com/articles/2024/8/5/fa9lt6ypbwx5su3z20xxnfzgtao0gy https://www.legalbusiness.co.uk/blogs/there-are-not-many-cases-like-this-the-withers-lawyers-in-imane-khelifs-corner/ https://www.lepoint.fr/monde/2024-olympics-imane-khelif-was-devastated-to-discover-out-of-the-blue-that-she-might-not-be-a-girl-14-08-2024-2567924_24.php#11

Written by 6DC10DF36A3B527CF2EC7F6D66F794C5A671E4DF4C81D1EA773421E7AD1C3C1C
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846349615953547367

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1846504191369281549
  • noteId - 1846504191369281549
  • participantId -
  • noteAuthorParticipantId - 6DC10DF36A3B527CF2EC7F6D66F794C5A671E4DF4C81D1EA773421E7AD1C3C1C Participant Details
  • createdAtMillis - 1729075880268
  • tweetId - 1846349615953547367
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Lin Yu-Ting and Imane Khelif never legally disputed genetic tests done in globally accredited labs showing XY karyotype. Khelif’s trainer admitted third test revealed ‘problems with chromosomes and hormones’; Khelif’s lawyers compare case to 46 XY DSD, Caster Semenya. https://www.3wiresports.com/articles/2024/8/5/fa9lt6ypbwx5su3z20xxnfzgtao0gy https://www.legalbusiness.co.uk/blogs/there-are-not-many-cases-like-this-the-withers-lawyers-in-imane-khelifs-corner/ https://www.lepoint.fr/monde/2024-olympics-imane-khelif-was-devastated-to-discover-out-of-the-blue-that-she-might-not-be-a-girl-14-08-2024-2567924_24.php#11

Note Ratings

rated at rated by
2024-10-17 15:18:48 -0500 Rating Details
2024-10-17 05:20:56 -0500 Rating Details
2024-10-17 00:49:24 -0500 Rating Details
2024-10-16 16:42:47 -0500 Rating Details
2024-10-16 16:38:35 -0500 Rating Details
2024-10-16 16:05:15 -0500 Rating Details
2024-10-16 15:54:07 -0500 Rating Details
2024-10-16 15:16:55 -0500 Rating Details
2024-10-16 15:08:24 -0500 Rating Details
2024-10-16 14:54:42 -0500 Rating Details
2024-10-16 14:52:22 -0500 Rating Details
2024-10-16 13:36:30 -0500 Rating Details
2024-10-16 13:29:27 -0500 Rating Details
2024-10-16 12:36:47 -0500 Rating Details
2024-10-16 12:28:55 -0500 Rating Details
2024-10-16 11:48:49 -0500 Rating Details
2024-10-16 11:34:39 -0500 Rating Details
2024-10-16 10:42:24 -0500 Rating Details
2024-10-16 10:21:13 -0500 Rating Details
2024-10-16 10:06:00 -0500 Rating Details
2024-10-16 09:56:31 -0500 Rating Details
2024-10-16 09:50:10 -0500 Rating Details
2024-10-16 09:25:28 -0500 Rating Details
2024-10-16 09:21:20 -0500 Rating Details
2024-10-16 09:04:15 -0500 Rating Details
2024-10-16 08:25:14 -0500 Rating Details
2024-10-16 08:16:27 -0500 Rating Details
2024-10-16 07:42:06 -0500 Rating Details
2024-10-16 07:35:10 -0500 Rating Details
2024-10-16 07:14:24 -0500 Rating Details
2024-10-16 20:25:15 -0500 Rating Details
2024-10-16 18:41:01 -0500 Rating Details
2024-10-16 18:20:39 -0500 Rating Details
2024-10-16 18:12:09 -0500 Rating Details
2024-10-16 16:49:37 -0500 Rating Details
2024-10-16 16:16:35 -0500 Rating Details
2024-10-16 16:08:01 -0500 Rating Details
2024-10-16 16:00:50 -0500 Rating Details
2024-10-16 15:46:15 -0500 Rating Details
2024-10-16 15:16:20 -0500 Rating Details
2024-10-16 15:01:57 -0500 Rating Details
2024-10-16 14:42:35 -0500 Rating Details
2024-10-16 14:28:07 -0500 Rating Details
2024-10-16 14:25:08 -0500 Rating Details
2024-10-16 13:59:09 -0500 Rating Details
2024-10-16 13:49:35 -0500 Rating Details
2024-10-16 13:30:03 -0500 Rating Details
2024-10-16 13:19:40 -0500 Rating Details
2024-10-16 12:04:58 -0500 Rating Details
2024-10-16 11:43:53 -0500 Rating Details
2024-10-16 11:37:39 -0500 Rating Details
2024-10-16 10:35:52 -0500 Rating Details
2024-10-16 10:07:57 -0500 Rating Details
2024-10-16 09:53:11 -0500 Rating Details
2024-10-16 09:26:59 -0500 Rating Details
2024-10-16 09:20:32 -0500 Rating Details
2024-10-16 08:58:20 -0500 Rating Details
2024-10-16 08:47:55 -0500 Rating Details
2024-10-16 07:43:55 -0500 Rating Details
2024-10-16 07:09:47 -0500 Rating Details
2024-10-17 08:12:23 -0500 Rating Details
2024-10-17 07:11:37 -0500 Rating Details
2024-10-17 05:32:32 -0500 Rating Details
2024-10-16 23:38:21 -0500 Rating Details
2024-10-16 23:25:37 -0500 Rating Details
2024-10-16 22:21:49 -0500 Rating Details
2024-10-16 20:23:40 -0500 Rating Details
2024-10-16 20:22:53 -0500 Rating Details
2024-10-16 19:53:33 -0500 Rating Details
2024-10-16 19:50:14 -0500 Rating Details
2024-10-16 17:14:23 -0500 Rating Details
2024-10-16 16:52:19 -0500 Rating Details
2024-10-16 16:36:42 -0500 Rating Details
2024-10-16 16:09:58 -0500 Rating Details
2024-10-16 14:26:40 -0500 Rating Details
2024-10-16 14:00:40 -0500 Rating Details
2024-10-16 12:22:44 -0500 Rating Details
2024-10-16 11:31:54 -0500 Rating Details
2024-10-16 10:55:13 -0500 Rating Details
2024-10-16 10:43:54 -0500 Rating Details
2024-10-16 09:53:01 -0500 Rating Details
2024-10-16 09:30:58 -0500 Rating Details
2024-10-16 09:30:20 -0500 Rating Details
2024-10-16 06:46:54 -0500 Rating Details
2024-10-16 06:14:58 -0500 Rating Details
2024-10-16 06:00:19 -0500 Rating Details
2024-10-17 11:22:04 -0500 Rating Details
2024-10-17 07:15:05 -0500 Rating Details
2024-10-16 21:02:49 -0500 Rating Details
2024-10-16 20:31:33 -0500 Rating Details
2024-10-16 16:18:30 -0500 Rating Details
2024-10-16 16:04:41 -0500 Rating Details
2024-10-16 14:48:23 -0500 Rating Details
2024-10-16 14:21:49 -0500 Rating Details
2024-10-16 10:53:12 -0500 Rating Details
2024-10-16 10:43:00 -0500 Rating Details
2024-10-16 10:15:06 -0500 Rating Details
2024-10-16 10:10:23 -0500 Rating Details
2024-10-16 10:05:43 -0500 Rating Details
2024-10-16 09:16:00 -0500 Rating Details
2024-10-16 08:02:02 -0500 Rating Details
2024-10-16 07:13:22 -0500 Rating Details
2024-10-17 10:47:06 -0500 Rating Details
2024-10-16 23:44:22 -0500 Rating Details
2024-10-16 23:36:24 -0500 Rating Details
2024-10-16 22:54:59 -0500 Rating Details
2024-10-16 18:27:39 -0500 Rating Details
2024-10-16 17:41:59 -0500 Rating Details
2024-10-16 17:29:10 -0500 Rating Details
2024-10-16 17:23:08 -0500 Rating Details
2024-10-16 17:05:27 -0500 Rating Details
2024-10-16 17:01:55 -0500 Rating Details
2024-10-16 14:57:25 -0500 Rating Details
2024-10-16 14:40:07 -0500 Rating Details
2024-10-16 14:39:39 -0500 Rating Details
2024-10-16 13:46:18 -0500 Rating Details
2024-10-16 13:40:14 -0500 Rating Details
2024-10-16 12:41:06 -0500 Rating Details
2024-10-16 12:16:44 -0500 Rating Details
2024-10-16 11:27:59 -0500 Rating Details
2024-10-16 11:01:47 -0500 Rating Details
2024-10-16 10:57:47 -0500 Rating Details
2024-10-16 10:32:26 -0500 Rating Details
2024-10-16 10:31:32 -0500 Rating Details
2024-10-16 10:28:50 -0500 Rating Details
2024-10-16 10:20:14 -0500 Rating Details
2024-10-16 09:53:48 -0500 Rating Details
2024-10-16 09:48:44 -0500 Rating Details
2024-10-16 09:12:26 -0500 Rating Details
2024-10-16 08:17:18 -0500 Rating Details
2024-10-16 07:59:55 -0500 Rating Details
2024-10-16 07:11:28 -0500 Rating Details